A detailed history of Panoramic Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Panoramic Capital, LLC holds 1,591 shares of LLY stock, worth $1.63 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
1,591
Previous 1,600 0.56%
Holding current value
$1.63 Million
Previous $1.25 Billion 2.67%
% of portfolio
0.55%
Previous 0.94%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$625.65 - $812.69 $5,630 - $7,314
-9 Reduced 0.56%
1,591 $1.21 Billion
Q2 2025

Aug 14, 2025

SELL
$713.71 - $898.95 $1.52 Million - $1.91 Million
-2,124 Reduced 57.04%
1,600 $1.25 Billion
Q1 2025

May 15, 2025

SELL
$725.72 - $929.72 $2.87 Million - $3.68 Million
-3,957 Reduced 51.52%
3,724 $3.08 Billion
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $5.59 Million - $7.16 Million
7,681 New
7,681 $5.93 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Panoramic Capital, LLC Portfolio

Follow Panoramic Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panoramic Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Panoramic Capital, LLC with notifications on news.